AMTX Recap, Options Ideas & More

Starting the Week Off with Strength: 

To kick off a new trading week yesterday morning, we posted a trio of fresh options ideas and for the most part we met with instant success. There were only two sets of contracts out of the nine we designated that didn’t post excellent moves on the session.

We had an updated set from DKNG which carried over from a solid performance for the stock last week, some daily calls in the SPY, and a post-earnings target with NRG. Here are the big winners and the total gains that were possible for anyone who caught our alerts:

DKNG Weekly $62-63 Calls.
$62: 2.58-7.10 (+175%)
$63: 2.21-6.20 (+180%)
_____

SPY 03/01 $383-385 Calls 
$383: 2.89-7.83 (+171%)
$384: 2.01-6.87 (+242%)
$58: 1.55-5.89 (+280%)
_____

NRG Weekly $39-40.50 Calls
$39: 1.76-3.80 (+116%)
$39.50: 1.80-3.20 (+78%)
_____

Fresh Earnings Plays: 
ZM Weekly $430-440 Calls
TGT Weekly $185-187.50 Calls 


Aemetis, Inc. AMTX

We also want to swing back around for AMTX, a stock we began tracking just five weeks ago on the morning of January 25th. Its performance was subdued for the first part of last month, but the leaps and bounds it has made into blue skies since then have been so impressive that we had to rehash it for you this morning.

From its low of 6.08 subsequent to our alert, AMTX has made a fantastic run up to a new high of 16.39 yesterday. That marked an upswing of 170% and it came thanks to the company’s revelation of a new 5-year growth plan, during which time it believes it can reach revenues of over a billion dollars.


Extended Watchlist:
FRCN, ARGQ, IMTL, GMEV, CTLE, BSSP, SAML, HPNN 

CAG Recap & More

Conagra Brands, Inc. CAG – Recap 

With the markets ripping again yesterday, one of the options ideas we had zeroed in on produced some really nice gain opportunities for us. We signaled the CAG 07/02 $33.50-34.50 Calls, and two out of three of those contracts logged double-bag gains on the day.

Here are the total ranges and possible profits that these calls provided:

CAG 07/02 $33.50-34.50 Calls
$33.50: 1.15-2.15 (+87%)
$34: .77-1.76 (+129%)
$34.50: .55-1.35 (+145%)

______

Fresh Ideas:
FDX 07/02 $149-155 Calls
STZ 07/02 $175-180 Calls



OncoCyte Corp. OCX

On OCX yesterday, we noticed a drastic change as the stock fell off a cliff on news that it would discontinue development of its DetermaDx liquid biopsy test. Purely from a technical perspective, we have to take notice when a stock gets chopped by half and falls to near annual lows in one session.

It leaves a lot of future opportunity for a bounceback on the table, so we’re going to signal a long term idea in the options chain, and begin monitoring the OCX 11/20 $2.50 Calls.


Extended Watchlist:
ERFB, ARGQ, LFER, PVHO, XALL

Get Our FREE Daily Reports!